FADD is required for multiple signaling events downstream of the receptor Fas

Cell Growth and Differentiation

Volumn 10, Issue 12, 1999, Pages 797-804

  Juo, Peter ^a   Woo, Michele Sue Ann ^a   Kuo, Calvin J ^a,b   Signorelli, Paola ^c   Biemann, Hans P ^d   Hannun, Yusuf A ^c   Blenis, John ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d GENZYME CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 2; CASPASE 3; CASPASE 7; CASPASE 8; CERAMIDE; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; M PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN KINASE C; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTIGENS, CD95; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CARRIER PROTEINS; CASPASE 8; CASPASE 9; CASPASES; CERAMIDES; ENZYME ACTIVATION; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; GENETIC COMPLEMENTATION TEST; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; JURKAT CELLS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; MUTAGENESIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES;

EID: 0033428024     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Peter, M. E., and Krammer, P. H. Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis. Curr. Opin. Immunol., 10: 545-551, 1998.
2. Nagata, S. Apoptosis by death factor Cell, 88: 355-365, 1997.
3. Trauth, B. C., Klas, C., Peters, A. M. J., Matzku, S., Moller, P., Falk, W., Debatin, K-M., and Krammer, P. H. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science (Washington DC), 245: 301-305, 1989.
4. Yonehara, S., Ishii, A., and Yonehara, M. A cell-killing monoclonal antibody (Anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med., 169: 1747-1756, 1989.
5. Abbas, A. K. Die and let live: eliminating dangerous lymphocytes. Cell, 84: 655-657, 1996.
6. Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., and Nagata, S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature (Lond.), 356: 314-317, 1992.
7. Rieux-Laucat, F., Deist, T. L., Hivroz, C., Roberts, I. A. G., Debatin, K. M., Fischer, A., and deVillartay, J. P. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science (Washington DC), 268: 1347-1349, 1995.
8. Fisher, G. H., Rosenberg, F. J., Straus, S. E., Dale, J. K., Middelton, L A., Lin, A. Y., Strober, W., Lenardo, M. J., and Puck, J. M. Dominant-interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell, 81: 935-946, 1995.
9. Chinnaiyan, A. M., O'Rourke, K., Tewari, M., and Dixit, V. M. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell, 81: 505-512, 1995.
10. Boldin, M. P., Varfolomeev, E. E., Pancer, Z., Mett, I. L., Camonis, J. H., and Wallach, D. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J. Biol. Chem., 270: 7795-7798, 1995.
11. Yang, X., Khosravi-Far, R., Chang, H. Y., and Baltimore, D. Daxx, a novel Fas-binding protein that activates JNK and apoptosis. 89: 1067-1076, 1997.
12. Stanger, B. Z., Leder, P., Lee, T-H., Kim, E., and Seed, B. RIP. A novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell, 81: 513-523, 1995.
13. Chu, K., Niu, X., and Williams, L. T. A Fas-associated protein factor, FAF-1, potentiates Fas-mediated apoptosis. Proc. Natl. Acad. Sci. USA, 92: 11894-11898, 1995.
14. Sato, T., Irie, S., Kitada, S., and Reed, J. C. FAP-1: a protein tyrosine phosphatase that associates with Fas. Science (Washington DC), 268: 411-415, 1995.
15. Okura, T., Gong, L., Kamitani, T., Wada, T., Okura, I., Wei, C-F., Chang, H-M., and Yeh, E. T. H. Protection against Fas/APO-1 - and tumor necrosis factor-mediated cell death by a novel protein, Sentrin. J. Immunol., 157: 4277-4281, 1996.
16. Kischkel, F. C., Hellbardt, S., Behrmann, I., Germer, M., Pawlita, M., Krammer, P. H., and Peter, M. E. Cytotoxicity-dependent APO-1 (Fas/ CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J., 14: 5579-5588, 1995.
17. Varfolomeev, E. E., Schuchmann, M., Luria, V., Chiannilkulchai, N., Beckmann, J. S., Mett, I. L., Rebrikov, D., Brodianski, V. M., Kemper, O. C., Kollet, O., Lapidot, T., Soffer, D., Sobe, T., Avraham, K. B., Goncharov, T., Holtmann, H., Lonai, P., and Wallach, D. Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity, 9: 267-276, 1998.
18. Muzio, M., Chinnaiyan, A. M., Kischkel, F. C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J. D., Zhang, M., Gentz, R., Mann, M., Krammer, P. H., Peter, M. E., and Dixit, V. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell, 85: 817-827, 1996.
19. Medema, J. P., Scaffidi, C., Kischkel, F. C., Shevchenko, A., Mann, M., Krammer, P. H., and Peter, M. E. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J., 16: 2794-2804, 1997.
20. Juo, P., Kuo, C. J., Yuan, J., and Blenis, J. Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade. Curr. Biol., 8: 1001-1008, 1998.
21. Boldin, M. P., Goncharov, T. M., Goltsev, Y. V., and Wallach, D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced death. Cell, 85: 803-815, 1996.
22. Kelliher, M. A., Grimm, S., Ishida, Y., Kuo, F., Stanger, B. Z., and Leder, P. The death domain kinase RIP mediates the TNF-induced NF-κB signal. Immunity, 8: 297-303, 1998.
23. Yen, W-C., Pompa, J. L de la McCurrach, M. E., Shu, H-B., Elia, A. J., Shahinian, A., Ng, M., Wakeham, A., Khoo, W., Mitchell, K., El-Deiry, W. S., Lowe, S. W., Goeddel, D. V., and Mak, T. W. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science (Washington DC), 279: 1954-1958, 1998.
24. Zhang, J., Cado, D., Chen, A., Kabra, N. H., and Winoto, A. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature (Lond.), 392: 296-300, 1998.
25. Ting, A. T., Pimentel-Muinos, F. X., and Seed, B. RIP mediates tumor necrosis factor receptor 1 activation of NF-κB but not Fas/APO-1-initiated apoptosis. EMBO J., 15: 6189-6196, 1996.
26. Walsh, C. M., Wen, B. G., Chinnaiyan, A. M., O'Rourke, K., Dixit, V. M., and Hedrick, S. M. A role for FADD in T cell activation and development. Immunity, 8: 439-449, 1998.
27. Newton, K., Harris, A. W., Bath, M. L., Smith, K. G. C., and Strasser, A. A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J., 17: 706-718, 1998.
28. Pellegrini, S., John, J., Shearer, M., Kerr, I. M., and Stark, G. R. Use of a selectable marker regulated by α interferon to obtain mutations in the signaling pathway. Mol. Cell. Biol., 9: 4605-4612, 1989.
29. John, J., McKendry, R., Pellegrini, S., Flavell, D., Kerr, I. M., and Stark, G. R. Isolation and characterization of a new mutant human cell line unresponsive to α and β interferons. Mol. Cell. Biol., 11: 4189-4195, 1991.
30. Muzio, M., Stockwell, B. R., Stennicke, H. R., Salvesen, G. S., and Dixit, V. M. An induced proximity model for caspase-8 activation. J. Biol. Chem., 273: 2926-2930, 1998.
31. Martin, D. A., Siegel, R. M., Zheng, L., and Lenardo, M. J. Membrane oligomerization and cleavage activates the caspase-3 (FLICE/MACHa1) death signal. J. Biol. Chem., 273: 4345-4349, 1998.
32. Memon, S. A., Hou, J-Z., Moreno, M. B., and Zacharchuk, C. M. Apoptosis induced by achimeric Fas/FLICE receptor: lack of requirement for Fas-or FADD-binding proteins. J. Immunol., 160: 2046-2049, 1998.
33. Yang, X., Chang, H. Y., and Baltimore, D. Autoproteolytic activation of pro-caspases by oligomerization. Mol. Cell, 1: 319-325, 1998.
34. Li, H., Zhu, H., Xu, C-J., and Yuan, J. Cleavage of BID by caspase 8 mediates the mitochondnal damage in the Fas pathway of apoptosis. Cell, 94: 491-501, 1998.
35. Luo, X., Budhihardjo, I., Zou, H., Slaughter, C., and Wang, X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell, 94: 481-490, 1998.
36. Hannun, Y. A. Functions of ceramide in coordinating cellular stress responses to stress. Science (Washington DC), 274: 1855-1859, 1996.
37. Cifone, M. G., DeMaria, R., Roncaioli, P., Rippo, M. R., Azuma, M., Lanier, L. L., Santoni, A., and Testi, R. Apoptotic signalling through CD95 (Fas/APO1) activates an acidic sphingomyelinase. J. Exp. Med., 180: 1547-1552, 1994.
38. Cifone, M. G., Roncaioli, P., Maria, R. D., Camarda, G., Santoni, A., Ruberti, G., and Testi, R. Multiple pathways originate at the Fas/APO-1 (CD95) receptor: sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal. EMBO J., 14: 5859-5868, 1995.
39. Gulbins, E., Bissonnette, R., Mahboubi, A., Martin, S., Nishioka, W., Brunner, T., Baler, G., Baier-Bittertich, G., Byrd, C., Lang, F., Kolesnick, R., Altman, A., and Green, D. Fas-induced apoptosis is mediated via a ceramide-initiated Ras signaling pathway. Immunity, 2: 341-351, 1995.
40. Tepper, C. G., Jayadev, S., Liu, B., Bielawska, A., Wolff, R., Yonehara, S., Hannun, Y. A., and Seldin, M. F. Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity. Proc. Natl. Acad. Sci. USA, 92. 8443-8447, 1995.
41. Juo, P., Kuo, C. J., Reynolds, S. E., Konz, R. F., Raingeaud, J., Davis, R. J., Biemann, H-P., and Blenis, J. Fas activation of the p38 mitogen-activated protein kinase signalling pathway requires ICE/CED-3 family proteases. Mol. Cell. Biol., 17: 24-35, 1997.
42. Cahill, M. A., Peter, M. E., Kischkel, F. C., Chinnaiyan, A. M., Dixit, V. M., Krammer, P. H., and Nordheim, A. CD95 (APO-1/Fas) induces activation of SAP kinases downstream of ICE-like proteases. Oncogene, 13: 2087-2096, 1996.
43. Huang, S., Jiang, Y., Li, Z., Nishida, E., Mathias, P., Lin, S., Ulevitch, R. J., Nemerow, G. R., and Han, J. Apoptosis signaling pathway in T cells is composed of ICE/Ced-3 family proteases and MAP kinase kinase 6b. Immunity, 6: 739-749, 1997.
44. Lenczowski, J. M., Dominguez, L., Eder, A. M., King, L B., Zacharchuk, C. M., and Ashwell, J. D. Lack of a role for Jun kinase and AP-1 in Fas-induced apoptosis. Mol. Cell. Biol., 17: 170-181, 1997.
45. Toyoshima, F., Moriguchi, T., and Nishida, E. Fas induces cytoplasmic apoptotic responses and activation of the MKK7-JNK/SAPK and MKK6-p38 pathways independent of CPP32-like proteases. J. Cell Biol., 139: 1005-1015, 1997.
46. Chang, H. Y., Nishitoh, H., Yang, X., Ichijo, H., and Baltimore, D. Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adaptor protein DAXX. Science (Washington DC), 281: 1860-1863, 1998.
47. Liu, Z-G., Hsu, H., Goeddel, D. V., and Karin, M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NFκB activation prevents cell death. Cell, 87: 565-576, 1996.
48. Wajant, H., Johannes, F. J., Haas, E., Siemienski, K., Schwenzer, R., Schubert, G., Weiss, T., Grell, M., and Scheurich, P. Dominant-negative FADD inhibits TNFR60-, Fas/Apo1-, and TRAIL-R/Apo2L-mediated cell death but not gene induction. Curr. Biol., 8: 113-116, 1998.
49. Schwandner, R., Wiegmann, K., Bernardo, K., Kreder, D., and Kronke, M. TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase. J. Biol, Chem., 273: 5916-5922, 1998.
50. Chinnaiyan, A. M., Tepper, C. G., Seldin, M. F., O'Rourke, K., Kischkel, F. C., Hellbardt, S., Krammer, P. H., Peter, M. E., and Dixit, V. M. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem., 271: 4961-4965, 1996.
51. Chinnaiyan, A. M., O'Rourke, K., Yu, G-L., Lyons, R. H., Garg, M., Duan, D. R., Xing, L., Gentz, R., Ni, J., and Dixit, V. M. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science (Washington DC), 274: 990-992, 1996.
52. Wiegmann, K., Schwandner, R., Krut, O., Yeh, W-C., Mak, T. W., and Kronke, M. Requirement of FADD for tumor necrosis factor-induced activation of acid sphingomyelinase. J. Biol. Chem., 274: 5267-5270, 1999.
53. Weiss, A., and Stobo, J. D. Requirement for the coexpression of T3 and the T cell antigen receptor on a malignant human T cell line. J. Exp. Med., 160: 1284-1299, 1984.
54. Powell, S. M., Petersen, G. M., Krush, A. J., Booker, S., Jen, J., Giardiello, F. M., Hamilton, S. R., Vogelstein, B., and Kinzler, K. W. Molecular diagnosis of familial adenomatous polyposis. N. Engl. J. Med., 329: 1982-1987, 1993.
55. Li, H., Bergeron, L., Cryns, V., Pasternack, M. S., Zhu, H., Shi, L., Greenberg, A., and Yuan, J. Activation of caspase-2 in apoptosis. J. Biol. Chem., 272: 21010-21017, 1997.
56. Zhang, J., Alter, N., Reed, J. C., Borner, C., Obeid, L. M., and Hannun, Y. A. Bcl-2 interrupts the ceramide-mediated pathway of cell death. Proc. Natl. Acad. Sci. USA, 93: 5325-5328, 1996.
57. Bligh, E. G., and Dyer, W. J. Can. J. Biochem. Physiol., 37: 911-917, 1959.
58. Preiss, J., Loomis, C. R., Bishop, W. R., Stein, R., Niedel, J. E., and Bell, R. M. J. Biol. Chem., 261: 8597-8600, 1986.
59. Veldhoven, P. P. V., Bishop, W. R., and Bell, R. M. Anal. Biochem., 183: 177-189, 1989.